Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of AGM

28th Mar 2014 12:54

RNS Number : 4746D
Sphere Medical Holding plc
28 March 2014
 



 

For Immediate Release 28 March 2014

 

Sphere Medical Holding plc

 

Result of Annual General Meeting

 

Cambridge, UK, 28 March 2014: Sphere Medical Holding plc (AIM: SPHR.L) ("Sphere Medical" or the "Company"), a leading developer of innovative monitoring and diagnostic products for the critical care setting, announces that at its Annual General Meeting held today at 11:00am at its offices, Harston Mill, Harston, Cambridge CB22 7GG, all resolutions were duly passed.

 

For information, details of the proxy voting for each resolution are provided on the Company's website under Investor Relations and then Shareholder Documents.

 

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875 222

Dr. Anthony Martin, Non-Executive Chairman

Dr. Wolfgang Rencken, Chief Executive Officer

Matthew Hall, Chief Financial Officer

Peel Hunt LLP

Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw

Jock Maxwell Macdonald

finnCap

Tel: +44 (0) 20 7220 0500

Geoff Nash / Simon Hicks

Stephen Norcross

Consilium Strategic Communications

 

Tel: +44 (0) 20 3709 5700

[email protected]

Mary-Jane Elliott

Amber Bielecka

Matthew Neal

Ivar Milligan

 

 

Notes for Editors

Sphere Medical (AIM: SPHR.L), is a medical device company developing a range of innovative monitoring and diagnostic devices designed to significantly improve patient care.

 

Sphere Medical's products deliver real time analysis of blood gases, electrolytes and drug levels with laboratory accuracy, at the patient's bedside. Sphere Medical's products can be used in a wide range of medical applications, enabling faster clinical decision making and improved patient outcomes, whilst reducing costs for healthcare payers.

 

Sphere Medical has entered into a collaboration agreement entered with Ortho-Clinical Diagnostics, Inc. for the development of Proxima and enhancement of Sphere's operational and production capabilities.

 

Sphere Medical has a number of partnerships with industry leading medical device companies and has received a strategic investment from Johnson & Johnson Development Corporation.

 

For further information, please visit www.spheremedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGQKFDPBBKDBNB

Related Shares:

Sphere Medical Holding
FTSE 100 Latest
Value8,415.25
Change0.00